Dr Matt E Brunson, MD in Pelham, AL - General Practice

Dr Matt E Brunson, MD is a General Practice physician based in Pelham, Alabama. Dr Matt E Brunson is licensed to practice in Alabama (license number 11237) and his current practice location is 2411 Royal Ln, Pelham, Alabama. He can be reached at his office (for appointments etc.) via phone at (205) 908-8770.

NPI number for Dr Matt E Brunson is 1053640763 and his current mailing address is 2411 Royal Ln, Pelham, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053640763.

Contact Information

	Dr Matt E Brunson, MD
	2411 Royal Ln, Pelham, AL 35124-2622
	(205) 908-8770
	(205) 733-9269

Physician's Profile

Full Name	Dr Matt E Brunson
Gender	Male
Speciality	General Practice
Location	2411 Royal Ln, Pelham, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053640763
Provider Enumeration Date: 12/09/2009
Last Update Date: 12/09/2009

Medical Identifiers

Medical identifiers for Dr Matt E Brunson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053640763	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	11237 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matt E Brunson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Matt E Brunson, MD 2411 Royal Ln, Pelham, AL 35124-2622 Ph: (205) 908-8770	Dr Matt E Brunson, MD 2411 Royal Ln, Pelham, AL 35124-2622 Ph: (205) 908-8770

News Archive

PKCI/HINT1 gene associated with mood regulation

Removing the PKCI/HINT1 gene from mice has an anti-depressant-like and anxiolytic-like effect. Researchers writing in the open access journal BMC Neuroscience applied a battery of behavioral tests to the PKCI/HINT1 knockout animals, concluding that the deleted gene may have an important role in mood regulation.

2015 Voices for Healthy Kids Progress Report highlights achievements of past year

Over the last two years, Voices for Healthy Kids, a joint initiative of the Robert Wood Johnson Foundation and the American Heart Association, has directly supported more than 50 coalitions, in 20 cities and states, working to help all young people grow up at a healthy weight.

Coca-Cola sold in California now contains little of cancer-causing chemical 4-methylimidizole

Carcinogenicity and regulation of caramel colorings by Michael Jacobson, (Executive Director, Center for Science in the Public Interest, USA), an article due to be published in the International Journal of Occupational and Environmental Health, states that Coca-Cola sold in California now contains little of the cancer-causing chemical 4-methylimidizole (4-MI).

Watson Pharmaceuticals signs exclusive, worldwide licensing agreement with Itero Biopharmaceuticals

Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.

FDA to post quarterly report of potential drug safety issues

The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been identified based on a review of reports in FDA's Adverse Event Reporting System (AERS).

Dr Matt E Brunson, MD - General Practice in Pelham, AL